Lipid Metabolism‐Driven CNS Repair via Targeted EV Delivery of PAF to Neurons
Journal of Extracellular Vesicles · 2026
DOI: 10.1002/jev2.70241 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Extracellular Vesicles, 2026. Verfasst von Shih-Yin Chen und 10 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Cellular and System Medicine, National Health Research Institutes, Miaoli, Taiwan. Hauptthemen laut MEDLINE: Neurons, Platelet Activating Factor, Lipid Metabolism, Extracellular Vesicles. Die Arbeit nennt 90 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Health Research Institutes.
Abstract (Originalsprache)
Platelet‐activating factor (PAF) is a potent phospholipid mediator with therapeutic potential in neuroregeneration, but its therapeutic application is hindered by rapid degradation and systemic proinflammatory effects. Here, we present an engineered extracellular vesicle (EV)‐based delivery strategy that stabilizes and targets PAF to sites of hippocampal injury, restoring neuronal structure and cognitive function. EVs derived from EP4 antagonist‐primed mesenchymal stem cells (GWEVs) exhibit enhanced secretion and selective enrichment of bioactive lipids, particularly PAF, which promotes neuroregeneration, attenuates gliosis and rescues spatial memory. Mechanistic studies reveal that PAF's therapeutic activity depends not on classical PTAFR engagement but on neuronal metabolism via PAF‐acetylhydrolase (PAFAH), particularly the PAFAH1B1 subunit. The hydrolysis‐resistant analogue MPAF fails to confer benefit, underscoring the requirement for enzymatic processing. To address translational needs, we developed a bioorthogonal click‐labelling platform that enables real‐time SPECT imaging of EV biodistribution while preserving function. GWEVs preferentially accumulate in injured hippocampi, confirming targeted delivery. This study defines a previously unrecognized lipid metabolism‐dependent repair mechanism and demonstrates the feasibility of leveraging EVs for CNS‐targeted delivery of labile lipid therapeutics. These findings offer a platform for advancing regenerative strategies in neurodegenerative diseases and traumatic brain injury.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Cellular and System Medicine, National Health Research Institutes, Miaoli, Taiwan.
- Institute of Biotechnology, National Tsing Hua University, Hsinchu, Taiwan.
- Institute of Biotechnology and Pharmaceutical Research, National Health Research Institutes, Miaoli, Taiwan.
- Institute of Biomedical Engineering and Nanomedicine, National Health Research Institutes, Zhunan, Miaoli County, Taiwan.
- Program in Tissue Engineering and Regenerative Medicine, National Chung Hsing University, Taichung City, Taiwan.
ORCID-Profile: Hua-Jung Li
Förderung
- National Health Research Institutes
Zitieren
APA
Chen, S. Y., Hsu, J. Y., Lo, C. F., Liu, Y. W., Liao, W. N., Luo, W. T., Chen, Y. J., Li, J. P., Chen, J. K., Tsou, L. K., & Li, H. J. (2026). Lipid Metabolism‐Driven CNS Repair via Targeted EV Delivery of PAF to Neurons. Journal of Extracellular Vesicles. https://doi.org/10.1002/jev2.70241
Vancouver
Chen SY, Hsu JY, Lo CF, Liu YW, Liao WN, Luo WT, et al. Lipid Metabolism‐Driven CNS Repair via Targeted EV Delivery of PAF to Neurons. Journal of Extracellular Vesicles. 2026. doi:10.1002/jev2.70241
BibTeX
@article{Chen2026,
author = {Chen, Shih-Yin and Hsu, Jing-Ya and Lo, Chen-Fu and Liu, Yu-Wei and Liao, Wei-Neng and Luo, Wen-Ting and Chen, Yu-Ju and Li, Jui-Ping and Chen, Jen-Kun and Tsou, Lun Kelvin and Li, Hua-Jung},
title = {Lipid Metabolism‐Driven CNS Repair via Targeted EV Delivery of PAF to Neurons},
journal = {Journal of Extracellular Vesicles},
year = {2026},
doi = {10.1002/jev2.70241}
}
EUVIMED